This service helps healthcare startups and organisations enter and expand into new markets across the EU, United Kingdom, and United States. Our service addresses regulatory, clinical, and market dynamics, providing actionable, research-driven go-to-market strategies supported by a global team of strategic and financial experts. The service includes comprehensive commercialisation plans covering pricing, distribution, and sales channels. Using proprietary methodologies, we incorporate value-based pricing and adapt to diverse reimbursement landscapes across these regions. 

We provide two service levels: a) A Light Version with diagnostic reviews, gap analyses, and targeted recommendations; and b) A Complete Version delivering full strategy development, including market positioning, business model validation, operational roadmaps, risk mitigation, and iterative feedback. The service also offers curated commercial introductions to key stakeholders, backed by thorough due diligence. Our market validation engages local healthcare professionals to quantify market potential and refine value propositions aligned with payer priorities. Core components include segmentation, targeting, pricing and reimbursement analysis, revenue optimisation, resource allocation, milestone tracking, and risk management. With extensive startup experience, we help clients avoid pitfalls, optimise patient access, demonstrate value, and realise the commercial potential of their healthcare innovations. Alira Health works together with its clients to provide a holistic and clear vision for every stage of their organisation evolution. This translates to corporate and commercial strategy for equity story preparation, go to market model development, market opportunity assessment, support to capital raise including introduction to VCs and Family Offices.